Phase I study of pemetrexed and pegylated liposomal doxorubicin in patients with refractory breast, ovarian, primary peritoneal, or fallopian tube cancer
Donald A. Richards, David Loesch, Svetislava J. Vukelja, Hillary Wu, William J. Hyman, Jeffery Nieves, Yunfei Wang, Simin Hu, Oluwatoyin O. Shonukan, Datchen F. Tai
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Phase I study of pemetrexed and pegylated liposomal doxorubicin in patients with refractory breast, ovarian, primary peritoneal, or fallopian tube cancer'. Together they form a unique fingerprint.